NASDAQ:MASI - Masimo Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$99.12 +0.14 (+0.14 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$99.12
Today's Range$98.70 - $99.64
52-Week Range$80.69 - $100.00
Volume193,698 shs
Average Volume503,835 shs
Market Capitalization$5.13 billion
P/E Ratio40.46
Dividend YieldN/A
Beta0.95

About Masimo (NASDAQ:MASI)

Masimo logoMasimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. Masimo Corporation has a strategic partnership with NU Hospitals. The company was founded in 1989 and is headquartered in Irvine, California.

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:MASI
CUSIP57479510
Phone949-297-7000

Debt

Debt-to-Equity RatioN/A
Current Ratio4.55
Quick Ratio3.86

Price-To-Earnings

Trailing P/E Ratio40.46
Forward P/E Ratio34.42
P/E Growth2.36

Sales & Book Value

Annual Sales$798.11 million
Price / Sales6.43
Cash Flow$3.0461 per share
Price / Cash32.54
Book Value$14.80 per share
Price / Book6.70

Profitability

EPS (Most Recent Fiscal Year)$2.45
Net Income$131.61 million
Net Margins15.99%
Return on Equity23.14%
Return on Assets18.33%

Miscellaneous

Employees1,400
Outstanding Shares51,780,000

Masimo (NASDAQ:MASI) Frequently Asked Questions

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

How were Masimo's earnings last quarter?

Masimo (NASDAQ:MASI) issued its earnings results on Wednesday, May, 2nd. The medical equipment provider reported $0.75 EPS for the quarter, topping analysts' consensus estimates of $0.69 by $0.06. The medical equipment provider had revenue of $212.90 million for the quarter, compared to the consensus estimate of $205.65 million. Masimo had a return on equity of 23.14% and a net margin of 15.99%. The company's revenue was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.57 earnings per share. View Masimo's Earnings History.

When is Masimo's next earnings date?

Masimo is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Masimo.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided EPS guidance of $2.88 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.81.

What price target have analysts set for MASI?

5 brokerages have issued 1 year target prices for Masimo's stock. Their predictions range from $94.00 to $108.00. On average, they anticipate Masimo's share price to reach $100.80 in the next twelve months. View Analyst Ratings for Masimo.

Who are some of Masimo's key competitors?

Who are Masimo's key executives?

Masimo's management team includes the folowing people:
  • Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 53)
  • Mr. Anand Sampath, Chief Operating Officer (Age 52)
  • Mr. Yongsam Lee, Exec. VP & Chief Information Officer (Age 53)
  • Mr. Thomas Samuel McClenahan, Exec. VP, Gen. Counsel & Corp. Sec. (Age 45)
  • Dr. Steven J. Barker M.D., Ph.D., Acting Chief Medical Officer and Director (Age 73)

Has Masimo been receiving favorable news coverage?

News stories about MASI stock have trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Masimo earned a daily sentiment score of 0.16 on Accern's scale. They also assigned news stories about the medical equipment provider an impact score of 45.66 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Who are Masimo's major shareholders?

Masimo's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.10%), Point72 Asset Management L.P. (2.67%), Old Mutual Global Investors UK Ltd. (1.82%), Prudential Financial Inc. (1.57%), Northern Trust Corp (1.41%) and Champlain Investment Partners LLC (1.34%). Company insiders that own Masimo stock include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.

Which major investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Russell Investments Group Ltd., American Century Companies Inc., Federated Investors Inc. PA, Allianz Asset Management GmbH, Allianz Asset Management GmbH, State of Tennessee Treasury Department and Mckinley Capital Management LLC Delaware. Company insiders that have sold Masimo company stock in the last year include Anand Sampath, Jon Coleman, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker and Yongsam Lee. View Insider Buying and Selling for Masimo.

Which major investors are buying Masimo stock?

MASI stock was purchased by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Champlain Investment Partners LLC, Citigroup Inc., Rockefeller Capital Management L.P., Westfield Capital Management Co. LP, Eagle Asset Management Inc., Massachusetts Financial Services Co. MA and Matarin Capital Management LLC. View Insider Buying and Selling for Masimo.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $99.12.

How big of a company is Masimo?

Masimo has a market capitalization of $5.13 billion and generates $798.11 million in revenue each year. The medical equipment provider earns $131.61 million in net income (profit) each year or $2.45 on an earnings per share basis. Masimo employs 1,400 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]


MarketBeat Community Rating for Masimo (MASI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  245 (Vote Outperform)
Underperform Votes:  235 (Vote Underperform)
Total Votes:  480
MarketBeat's community ratings are surveys of what our community members think about Masimo and other stocks. Vote "Outperform" if you believe MASI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MASI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Masimo (NASDAQ:MASI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Masimo in the last 12 months. Their average twelve-month price target is $100.80, suggesting that the stock has a possible upside of 1.69%. The high price target for MASI is $108.00 and the low price target for MASI is $94.00. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.832.802.57
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $100.80$102.1667$106.25$97.00
Price Target Upside: 1.69% upside18.13% upside23.55% upside12.79% upside

Masimo (NASDAQ:MASI) Consensus Price Target History

Price Target History for Masimo (NASDAQ:MASI)

Masimo (NASDAQ:MASI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/3/2018BTIG ResearchReiterated RatingBuy$100.00HighView Rating Details
5/2/2018Piper Jaffray CompaniesBoost Price TargetNeutral$94.00HighView Rating Details
3/9/2018BarclaysInitiated CoverageOverweight ➝ Overweight$97.00MediumView Rating Details
11/3/2017Stifel NicolausReiterated RatingBuy$108.00N/AView Rating Details
7/19/2017Roth CapitalBoost Price TargetBuy$96.00 ➝ $105.00LowView Rating Details
5/22/2017WedbushReiterated RatingOutperform$112.00LowView Rating Details
2/13/2017Raymond JamesDowngradeOutperform ➝ Market PerformN/AView Rating Details
2/13/2017CitigroupDowngradeMarket Perform$60.00N/AView Rating Details
(Data available from 5/26/2016 forward)

Earnings

Masimo (NASDAQ:MASI) Earnings History and Estimates Chart

Earnings by Quarter for Masimo (NASDAQ:MASI)

Masimo (NASDAQ:MASI) Earnings Estimates

2018 EPS Consensus Estimate: $2.65
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.63$0.63$0.63
Q2 20182$0.65$0.76$0.71
Q3 20182$0.64$0.67$0.66
Q4 20182$0.61$0.70$0.66
Q2 20191$0.77$0.77$0.77
Q3 20191$0.72$0.72$0.72
Q4 20191$0.82$0.82$0.82

Masimo (NASDAQ MASI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2018        
5/2/2018Q1 2018$0.69$0.75$205.65 million$212.90 millionViewN/AView Earnings Details
2/27/2018Q4 2017$0.61$0.72$201.54 million$225.20 millionViewListenView Earnings Details
10/31/2017Q3 2017$0.53$0.70$189.01 million$193.69 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.71$0.83$189.03 million$192.90 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.60$0.82$184.14 million$186.30 millionViewListenView Earnings Details
2/14/2017Q416$0.52$0.51$180.48 million$183.20 millionViewListenView Earnings Details
11/2/2016Q316$0.42$0.52$165.51 million$167.60 millionViewListenView Earnings Details
8/3/2016Q216$0.41$0.57$166.02 million$172.64 millionViewListenView Earnings Details
5/4/2016Q116$0.43$0.53$165.25 million$171.20 millionViewListenView Earnings Details
2/23/2016Q415$0.39$0.15$164.25 million$167.30 millionViewListenView Earnings Details
11/5/2015Q315$0.31$0.36$149.31 million$152.60 millionViewListenView Earnings Details
8/4/2015Q215$0.32$0.43$147.93 million$155.73 millionViewListenView Earnings Details
5/6/2015Q115$0.35$0.41$151.00 million$154.54 millionViewListenView Earnings Details
2/17/2015Q414$0.37$0.40$159.45 million$161.80 millionViewListenView Earnings Details
10/29/2014Q314$0.25$0.27$144.20 million$144.10 millionViewListenView Earnings Details
8/7/2014Q214$0.29$0.27$145.76 million$140.92 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.39$144.01 million$139.80 millionViewListenView Earnings Details
2/13/2014Q413$0.31$0.31$148.25 million$134.70 millionViewListenView Earnings Details
10/30/2013Q313$0.26$0.27$132.47 million$131.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.28$0.30$136.36 million$137.42 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.28$0.28$134.46 million$135.90 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.29$0.26$129.09 million$132.20 millionViewListenView Earnings Details
11/1/2012Q312$0.26$0.26$120.99 million$112.10 millionViewN/AView Earnings Details
8/1/2012$0.28$0.27ViewN/AView Earnings Details
5/2/2012$0.28$0.27ViewN/AView Earnings Details
2/14/2012$0.23$0.23ViewN/AView Earnings Details
10/25/2011$0.27$0.24ViewN/AView Earnings Details
8/9/2011$0.28$0.28ViewN/AView Earnings Details
5/3/2011$0.30$0.30ViewN/AView Earnings Details
2/15/2011$0.26$0.29ViewN/AView Earnings Details
11/2/2010Q3 2010$0.25$0.27ViewN/AView Earnings Details
8/3/2010Q2 2010$0.25$0.25ViewN/AView Earnings Details
5/4/2010Q1 2010$0.23$0.24ViewN/AView Earnings Details
2/16/2010Q4 2009$0.22$0.23ViewN/AView Earnings Details
11/3/2009Q3 2009$0.21$0.22ViewN/AView Earnings Details
8/4/2009Q2 2009$0.21$0.22ViewN/AView Earnings Details
5/5/2009Q1 2009$0.19$0.22ViewN/AView Earnings Details
3/3/2009Q4 2008$0.18$0.24ViewN/AView Earnings Details
10/27/2008Q3 2008$0.16$0.22ViewN/AView Earnings Details
8/4/2008Q2 2008$0.14$0.18ViewN/AView Earnings Details
4/29/2008Q1 2008$0.11$0.15ViewN/AView Earnings Details
2/26/2008Q4 2007$0.13$0.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Masimo (NASDAQ:MASI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Masimo (NASDAQ MASI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 12.60%
Institutional Ownership Percentage: 82.92%
Insider Trading History for Masimo (NASDAQ:MASI)
Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Masimo (NASDAQ MASI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/4/2018Ramshorst David J VanCAOSell3,000$97.50$292,500.002,500View SEC Filing  
5/3/2018Jon ColemanInsiderSell50,000$93.75$4,687,500.0034,201View SEC Filing  
5/3/2018Sanford FitchDirectorSell2,000$94.00$188,000.0062,249View SEC Filing  
4/30/2018Sanford FitchDirectorSell2,000$90.37$180,740.0064,249View SEC Filing  
4/27/2018Yongsam LeeEVPSell5,800$90.58$525,364.0073,975View SEC Filing  
4/24/2018Yongsam LeeEVPSell4,100$90.13$369,533.0072,200View SEC Filing  
4/23/2018Jon ColemanInsiderSell24,000$90.00$2,160,000.0021,201View SEC Filing  
4/2/2018Sanford FitchDirectorSell2,000$86.02$172,040.0066,249View SEC Filing  
3/29/2018Jon ColemanInsiderSell29,303$87.50$2,564,012.5020,504View SEC Filing  
3/13/2018Yongsam LeeEVPSell100$90.00$9,000.0071,100View SEC Filing  
2/1/2018Sanford FitchDirectorSell2,000$93.07$186,140.0068,249View SEC Filing  
2/1/2018Yongsam LeeEVPSell10,000$92.95$929,500.0079,000View SEC Filing  
1/25/2018Sanford FitchDirectorSell2,000$90.00$180,000.0070,249View SEC Filing  
1/5/2018Yongsam LeeEVPSell10,000$88.17$881,700.0075,018View SEC Filing  
12/4/2017Yongsam LeeEVPSell18,198$88.85$1,616,892.3070,800View SEC Filing  
12/1/2017Yongsam LeeEVPSell5,900$88.31$521,029.0070,800View SEC Filing  
11/9/2017Yongsam LeeEVPSell13,976$89.43$1,249,873.6874,000View SEC Filing  
11/1/2017Steven BarkerDirectorSell10,000$90.00$900,000.0073,249View SEC Filing  
11/1/2017Yongsam LeeEVPSell5,000$89.89$449,450.0074,000View SEC Filing  
8/17/2017Sanford FitchDirectorSell11,000$87.25$959,750.0072,249View SEC Filing  
7/20/2017Jon ColemanInsiderSell25,000$97.50$2,437,500.0032,201View SEC Filing  
7/14/2017Rick FishelInsiderSell15,000$94.85$1,422,750.0035,022View SEC Filing  
7/13/2017Sanford FitchDirectorSell6,000$91.89$551,340.0089,249View SEC Filing  
7/11/2017Anand SampathCOOSell40,000$92.00$3,680,000.0020,000View SEC Filing  
7/11/2017Rick FishelInsiderSell15,000$92.85$1,392,750.0035,022View SEC Filing  
6/29/2017Sanford FitchDirectorSell14,000$92.06$1,288,840.0090,249View SEC Filing  
5/1/2017Joe E KianiCEOSell145,841$102.37$14,929,743.17165,082View SEC Filing  
4/28/2017Thomas Samuel McclenahanEVPSell8,000$102.75$822,000.002,000View SEC Filing  
4/26/2017Joe E KianiCEOSell154,159$99.70$15,369,652.30219,241View SEC Filing  
4/25/2017Joe E KianiCEOSell13,201$101.00$1,333,301.00219,241View SEC Filing  
4/25/2017Jon ColemanInsiderSell50,000$100.00$5,000,000.0014,682View SEC Filing  
4/25/2017Yongsam LeeEVPSell10,000$100.00$1,000,000.0079,000View SEC Filing  
4/24/2017Joe E KianiCEOSell100,000$99.00$9,900,000.00219,241View SEC Filing  
4/24/2017Thomas Samuel McclenahanEVPSell10,000$98.75$987,500.0010,000View SEC Filing  
4/20/2017Thomas Samuel McclenahanEVPSell10,000$95.75$957,500.004,000View SEC Filing  
4/19/2017Yongsam LeeEVPSell10,000$95.00$950,000.0079,000View SEC Filing  
4/4/2017Raad Mark DeCFOSell48,000$93.25$4,476,000.0014,660View SEC Filing  
3/22/2017Sanford FitchDirectorSell3,000$93.23$279,690.0080,000View SEC Filing  
3/10/2017Paul JansenEVPSell55,611$94.47$5,253,571.1710,000View SEC Filing  
3/9/2017Ramshorst David J VanInsiderSell7,500$94.20$706,500.002,500View SEC Filing  
2/23/2017Raad Mark DeCFOSell30,000$86.25$2,587,500.0017,660View SEC Filing  
2/17/2017Raad Mark DeCFOSell45,000$80.00$3,600,000.0017,660View SEC Filing  
2/16/2017Joe E KianiCEOSell300,000$80.04$24,012,000.00119,241View SEC Filing  
2/3/2017Jon ColemanInsiderSell6,000$75.00$450,000.0013,182View SEC Filing  
2/3/2017Raad Mark DeCFOSell15,000$75.00$1,125,000.0017,660View SEC Filing  
1/27/2017Jon ColemanInsiderSell5,800$72.50$420,500.008,707View SEC Filing  
1/27/2017Raad Mark DeCFOSell15,000$72.50$1,087,500.0017,660View SEC Filing  
1/20/2017Jon ColemanInsiderSell200$72.50$14,500.007,282View SEC Filing  
1/13/2017Yongsam LeeEVPSell10,000$72.00$720,000.0079,000View SEC Filing  
1/10/2017Jon ColemanInsiderSell6,000$70.00$420,000.0013,182View SEC Filing  
1/10/2017Raad Mark DeCFOSell15,000$70.00$1,050,000.0017,660View SEC Filing  
1/10/2017Yongsam LeeEVPSell10,000$70.00$700,000.0079,000View SEC Filing  
1/9/2017Paul JansenEVPSell17,945$68.88$1,236,051.6017,945View SEC Filing  
1/3/2017Ramshorst David J VanInsiderSell4,000$67.20$268,800.005,000View SEC Filing  
12/27/2016Paul JansenEVPSell2,055$68.88$141,548.402,055View SEC Filing  
12/21/2016Jon ColemanInsiderSell4,000$67.50$270,000.004,459View SEC Filing  
12/16/2016Thomas Samuel McclenahanEVPSell10,000$66.00$660,000.0010,000View SEC Filing  
12/8/2016Paul JansenEVPSell10,000$63.88$638,800.005,000View SEC Filing  
12/7/2016Thomas Samuel McclenahanEVPSell2,293$63.00$144,459.004,000View SEC Filing  
12/6/2016Joe E KianiCEOSell52,859$62.03$3,278,843.77119,241View SEC Filing  
12/6/2016Thomas Samuel McclenahanEVPSell4,000$63.00$252,000.004,000View SEC Filing  
12/1/2016Joe E KianiCEOSell36,119$62.06$2,241,545.14119,241View SEC Filing  
11/29/2016Joe E KianiCEOSell104,870$62.27$6,530,254.90119,241View SEC Filing  
11/23/2016Joe E KianiCEOSell85,771$62.06$5,322,948.26119,241View SEC Filing  
11/22/2016Joe E KianiCEOSell869$62.00$53,878.00119,241View SEC Filing  
11/21/2016Joe E KianiCEOSell30,462$62.04$1,889,862.48119,241View SEC Filing  
11/18/2016Joe E KianiCEOSell20,381$62.02$1,264,029.62119,241View SEC Filing  
11/1/2016Anand SampathCOOSell65,000$55.04$3,577,600.0023,171View SEC Filing  
10/31/2016Anand SampathCOOSell51,345$55.05$2,826,542.2523,171View SEC Filing  
10/19/2016Sanford FitchDirectorSell2,000$59.05$118,100.0046,000View SEC Filing  
10/10/2016Joe E KianiCEOSell84,617$60.26$5,099,020.42126,450View SEC Filing  
10/10/2016Yongsam LeeEVPSell30,000$60.50$1,815,000.0093,000View SEC Filing  
10/5/2016Sanford FitchDirectorSell2,000$59.58$119,160.0048,000View SEC Filing  
10/4/2016Joe E KianiCEOSell4,300$60.07$258,301.00121,441View SEC Filing  
10/3/2016Joe E KianiCEOSell2,200$60.00$132,000.00121,441View SEC Filing  
9/30/2016Thomas Samuel McclenahanEVPSell10,000$59.00$590,000.0010,000View SEC Filing  
9/27/2016Joe E KianiCEOSell4,464$60.01$267,884.64123,705View SEC Filing  
9/22/2016Joe E KianiCEOSell49,484$60.18$2,977,947.12158,911View SEC Filing  
9/21/2016Sanford FitchDirectorSell2,000$59.41$118,820.0050,000View SEC Filing  
9/20/2016Joe E KianiCEOSell400$60.16$24,064.00120,240View SEC Filing  
9/19/2016Joe E KianiCEOSell999$60.03$59,969.97120,240View SEC Filing  
9/7/2016Joe E KianiCEOSell33,536$60.00$2,012,160.00152,777View SEC Filing  
9/7/2016Jon ColemanInsiderSell6,000$60.00$360,000.00759View SEC Filing  
9/7/2016Sanford FitchDirectorSell2,000$59.81$119,620.00View SEC Filing  
8/17/2016Sanford FitchDirectorSell2,000$58.11$116,220.0054,000View SEC Filing  
8/4/2016Jon ColemanInsiderSell22,000$56.82$1,250,040.0010,459View SEC Filing  
8/4/2016Paul JansenEVPSell10,000$58.88$588,800.0010,000View SEC Filing  
8/3/2016Sanford FitchDirectorSell2,000$52.62$105,240.0056,000View SEC Filing  
7/20/2016Rick FishelInsiderSell22,000$53.85$1,184,700.0042,022View SEC Filing  
7/20/2016Sanford FitchDirectorSell3,000$53.48$160,440.0058,000View SEC Filing  
6/30/2016Ramshorst David J VanCAOSell5,000$52.50$262,500.003,000View SEC Filing  
6/7/2016Joe E KianiCEOSell65,048$50.00$3,252,400.00175,818View SEC Filing  
6/3/2016Joe E KianiCEOSell234,952$50.09$11,768,745.68313,797View SEC Filing  
6/1/2016Jon ColemanInsiderSell4,000$50.00$200,000.004,459View SEC Filing  
5/31/2016Raad Mark DeCFOSell40,000$49.43$1,977,200.0042,660View SEC Filing  
5/25/2016Rick FishelInsiderSell25,000$49.85$1,246,250.0052,022View SEC Filing  
5/5/2016Jon ColemanInsiderSell8,000$47.00$376,000.004,459View SEC Filing  
4/28/2016Paul JansenEVPSell10,000$44.88$448,800.0010,000View SEC Filing  
4/27/2016Jon ColemanInsiderSell4,000$44.00$176,000.004,459View SEC Filing  
3/23/2016Yongsam LeeEVPSell96,000$39.96$3,836,160.00133,000View SEC Filing  
3/22/2016Yongsam LeeEVPSell32,000$40.06$1,281,920.00133,000View SEC Filing  
3/21/2016Yongsam LeeEVPSell32,000$39.83$1,274,560.00133,000View SEC Filing  
3/15/2016Raad Mark DeCFOSell40,000$39.00$1,560,000.0042,660View SEC Filing  
2/29/2016Raad Mark DeCFOSell40,000$38.11$1,524,400.0042,660View SEC Filing  
12/24/2015Jon ColemaninsiderSell10,000$42.00$420,000.00459View SEC Filing  
12/9/2015Sanford FitchDirectorSell2,000$41.00$82,000.0061,000View SEC Filing  
11/11/2015Sanford FitchDirectorSell2,000$42.67$85,340.0061,000View SEC Filing  
11/6/2015Anand SampathCOOSell45,000$42.00$1,890,000.00View SEC Filing  
11/6/2015Jon ColemaninsiderSell10,000$42.38$423,800.00459View SEC Filing  
10/14/2015Sanford FitchDirectorSell2,000$39.29$78,580.0061,000View SEC Filing  
9/17/2015Paul JansenEVPSell10,000$42.88$428,800.00View SEC Filing  
9/9/2015Sanford FitchDirectorSell2,000$41.29$82,580.0061,000View SEC Filing  
8/31/2015Thomas Samuel McclenahanEVPSell22,000$40.62$893,640.00View SEC Filing  
8/26/2015Paul JansenEVPSell10,000$40.88$408,800.00View SEC Filing  
7/22/2015Rick FishelInsiderSell35,084$41.85$1,468,265.40View SEC Filing  
7/21/2015Joe E KianiCEOSell300,000$40.55$12,165,000.00View SEC Filing  
7/21/2015Steven BarkerDirectorSell20,000$40.00$800,000.00View SEC Filing  
7/8/2015Sanford FitchDirectorSell2,000$38.18$76,360.00View SEC Filing  
6/10/2015Sanford FitchDirectorSell2,000$36.49$72,980.00View SEC Filing  
6/4/2015Steven BarkerDirectorSell25,000$36.20$905,000.00View SEC Filing  
4/8/2015Sanford FitchDirectorSell2,000$34.57$69,140.00View SEC Filing  
2/18/2015Rick FishelInsiderSell18,170$29.85$542,374.50View SEC Filing  
5/22/2013Robert ColemanDirectorSell59,400$21.93$1,302,642.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Masimo (NASDAQ MASI) News Headlines

Source:
DateHeadline
Masimo (MASI) Expected to Post Quarterly Sales of $209.05 MillionMasimo (MASI) Expected to Post Quarterly Sales of $209.05 Million
www.americanbankingnews.com - May 25 at 5:59 AM
Masimo (MASI) Expected to Announce Earnings of $0.73 Per ShareMasimo (MASI) Expected to Announce Earnings of $0.73 Per Share
www.americanbankingnews.com - May 23 at 1:14 AM
Womens Tennis Association to Use Masimo MightySat™ Fingertip Pulse Oximeters to Advance Player Health and ...Women's Tennis Association to Use Masimo MightySat™ Fingertip Pulse Oximeters to Advance Player Health and ...
www.businesswire.com - May 21 at 10:17 AM
Head to Head Survey: Masimo (MASI) and NxStage (NXTM)Head to Head Survey: Masimo (MASI) and NxStage (NXTM)
www.americanbankingnews.com - May 20 at 1:19 AM
Contrasting Varian Medical Systems (VAR) and Masimo (MASI)Contrasting Varian Medical Systems (VAR) and Masimo (MASI)
www.americanbankingnews.com - May 16 at 3:16 AM
New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with ...New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with ...
www.businesswire.com - May 14 at 11:35 AM
Masimo: Superb Q1, But The Stock Is Too HighMasimo: Superb Q1, But The Stock Is Too High
seekingalpha.com - May 14 at 11:35 AM
BidaskClub Downgrades Masimo (MASI) to BuyBidaskClub Downgrades Masimo (MASI) to Buy
www.americanbankingnews.com - May 14 at 10:46 AM
BidaskClub Upgrades Masimo (MASI) to Strong-BuyBidaskClub Upgrades Masimo (MASI) to Strong-Buy
www.americanbankingnews.com - May 8 at 3:49 PM
Masimo (MASI) Rating Increased to Buy at ValuEngineMasimo (MASI) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - May 7 at 10:36 PM
Zacks Investment Research Lowers Masimo (MASI) to HoldZacks Investment Research Lowers Masimo (MASI) to Hold
www.americanbankingnews.com - May 7 at 2:31 PM
Masimo SET® Pulse Oximetry Helps Form Basis of Utah Senate Resolution on Postoperative Oxygen Saturation Home Monitoring for Patients Prescribed OpioidsMasimo SET® Pulse Oximetry Helps Form Basis of Utah Senate Resolution on Postoperative Oxygen Saturation Home Monitoring for Patients Prescribed Opioids
finance.yahoo.com - May 7 at 10:32 AM
FY2018 EPS Estimates for Masimo (MASI) Raised by AnalystFY2018 EPS Estimates for Masimo (MASI) Raised by Analyst
www.americanbankingnews.com - May 7 at 3:46 AM
$208.91 Million in Sales Expected for Masimo (MASI) This Quarter$208.91 Million in Sales Expected for Masimo (MASI) This Quarter
www.americanbankingnews.com - May 7 at 2:52 AM
$0.73 EPS Expected for Masimo (MASI) This Quarter$0.73 EPS Expected for Masimo (MASI) This Quarter
www.americanbankingnews.com - May 5 at 3:12 PM
Insider Selling: Masimo (MASI) CAO Sells 3,000 Shares of StockInsider Selling: Masimo (MASI) CAO Sells 3,000 Shares of Stock
www.americanbankingnews.com - May 4 at 10:15 PM
Masimo (MASI) Director Sells $188,000.00 in StockMasimo (MASI) Director Sells $188,000.00 in Stock
www.americanbankingnews.com - May 4 at 7:52 PM
Masimo (MASI) Insider Sells $4,687,500.00 in StockMasimo (MASI) Insider Sells $4,687,500.00 in Stock
www.americanbankingnews.com - May 4 at 7:32 PM
Masimo (MASI) Lifted to "Buy" at Zacks Investment ResearchMasimo (MASI) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - May 4 at 5:46 PM
Masimo (MASI) Beats on Q1 Earnings, Raises '18 GuidanceMasimo (MASI) Beats on Q1 Earnings, Raises '18 Guidance
finance.yahoo.com - May 4 at 3:50 PM
Masimo (MASI) Beats on Q1 Earnings, Raises 18 GuidanceMasimo (MASI) Beats on Q1 Earnings, Raises '18 Guidance
www.zacks.com - May 4 at 10:10 AM
Q2 2018 EPS Estimates for Masimo Raised by Analyst (MASI)Q2 2018 EPS Estimates for Masimo Raised by Analyst (MASI)
www.americanbankingnews.com - May 4 at 7:36 AM
Masimo (MASI) Earns "Buy" Rating from BTIG ResearchMasimo (MASI) Earns "Buy" Rating from BTIG Research
www.americanbankingnews.com - May 3 at 6:46 PM
Masimo (MASI) and Its Peers Financial AnalysisMasimo (MASI) and Its Peers Financial Analysis
www.americanbankingnews.com - May 3 at 4:02 PM
BRIEF-Masimo Q1 GAAP Earnings Per Share $0.82BRIEF-Masimo Q1 GAAP Earnings Per Share $0.82
www.reuters.com - May 3 at 10:10 AM
Masimo Corporation 2018 Q1 - Results - Earnings Call SlidesMasimo Corporation 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 3 at 10:10 AM
Masimo: 1Q Earnings SnapshotMasimo: 1Q Earnings Snapshot
finance.yahoo.com - May 3 at 10:10 AM
Masimo Reports First Quarter 2018 Financial ResultsMasimo Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 3 at 10:10 AM
Masimo Corporation's Strong First Quarter Spurs an Upgrade to Its 2018 OutlookMasimo Corporation's Strong First Quarter Spurs an Upgrade to Its 2018 Outlook
finance.yahoo.com - May 3 at 10:10 AM
Edited Transcript of MASI earnings conference call or presentation 2-May-18 8:30pm GMTEdited Transcript of MASI earnings conference call or presentation 2-May-18 8:30pm GMT
finance.yahoo.com - May 3 at 10:10 AM
Masimo Corporations Strong First Quarter Spurs an Upgrade to Its 2018 OutlookMasimo Corporation's Strong First Quarter Spurs an Upgrade to Its 2018 Outlook
www.fool.com - May 3 at 7:18 AM
Masimo (MASI) Given Average Recommendation of "Buy" by BrokeragesMasimo (MASI) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 3 at 1:40 AM
Masimo (MASI) PT Raised to $94.00Masimo (MASI) PT Raised to $94.00
www.americanbankingnews.com - May 2 at 11:06 PM
Masimo (MASI) Issues  Earnings Results, Beats Expectations By $0.06 EPSMasimo (MASI) Issues Earnings Results, Beats Expectations By $0.06 EPS
www.americanbankingnews.com - May 2 at 7:32 PM
Masimo (MASI) Issues FY18 Earnings GuidanceMasimo (MASI) Issues FY18 Earnings Guidance
www.americanbankingnews.com - May 2 at 7:30 PM
Masimo to Present at Deutsche Bank 43rd Annual Health Care ConferenceMasimo to Present at Deutsche Bank 43rd Annual Health Care Conference
finance.yahoo.com - May 2 at 10:14 AM
Masimo (MASI) versus Its Rivals Head-To-Head SurveyMasimo (MASI) versus Its Rivals Head-To-Head Survey
www.americanbankingnews.com - May 2 at 5:24 AM
Head to Head Analysis: Masimo (MASI) & The CompetitionHead to Head Analysis: Masimo (MASI) & The Competition
www.americanbankingnews.com - May 1 at 9:14 PM
Brain Function Monitoring Power Two Investigations into Postoperative Delirium Presented at IARSBrain Function Monitoring Power Two Investigations into Postoperative Delirium Presented at IARS
www.businesswire.com - May 1 at 3:43 PM
Masimo (MASI) Downgraded by Zacks Investment Research to HoldMasimo (MASI) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - May 1 at 12:26 PM
Masimo O3® Regional Oximetry and SedLine® Brain Function Monitoring Power Two Investigations into Postoperative Delirium Presented at IARSMasimo O3® Regional Oximetry and SedLine® Brain Function Monitoring Power Two Investigations into Postoperative Delirium Presented at IARS
finance.yahoo.com - May 1 at 10:18 AM
Masimo (MASI) EVP Sells $525,364.00 in StockMasimo (MASI) EVP Sells $525,364.00 in Stock
www.americanbankingnews.com - April 30 at 7:46 PM
Masimo (MASI) Director Sanford Fitch Sells 2,000 SharesMasimo (MASI) Director Sanford Fitch Sells 2,000 Shares
www.americanbankingnews.com - April 30 at 7:44 PM
Does Masimo Corporation’s (NASDAQ:MASI) PE Ratio Signal A Selling Opportunity?Does Masimo Corporation’s (NASDAQ:MASI) PE Ratio Signal A Selling Opportunity?
finance.yahoo.com - April 29 at 10:29 AM
Financial Comparison: Masimo (MASI) and Its PeersFinancial Comparison: Masimo (MASI) and Its Peers
www.americanbankingnews.com - April 28 at 3:18 PM
Head-To-Head Analysis: Masimo (MASI) & Its PeersHead-To-Head Analysis: Masimo (MASI) & Its Peers
www.americanbankingnews.com - April 28 at 3:06 AM
Head to Head Review: Masimo (MASI) versus Its PeersHead to Head Review: Masimo (MASI) versus Its Peers
www.americanbankingnews.com - April 27 at 7:04 PM
Analyzing Masimo (MASI) and The CompetitionAnalyzing Masimo (MASI) and The Competition
www.americanbankingnews.com - April 27 at 5:20 PM
Masimo (MASI) EVP Sells $369,533.00 in StockMasimo (MASI) EVP Sells $369,533.00 in Stock
www.americanbankingnews.com - April 25 at 10:16 PM
Jon Coleman Sells 24,000 Shares of Masimo (MASI) StockJon Coleman Sells 24,000 Shares of Masimo (MASI) Stock
www.americanbankingnews.com - April 25 at 10:16 PM

SEC Filings

Masimo (NASDAQ:MASI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Masimo (NASDAQ:MASI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Masimo (NASDAQ MASI) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.